US Stock MarketDetailed Quotes

OKUR OnKure Therapeutics

Watchlist

15.420
+0.660+4.47%

Close Nov 29 13:00 ET

205.69MMarket Cap-1568P/E (TTM)

OnKure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OnKure Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--------

Unlock Free Earnings Estimates

Open Account

OnKure Therapeutics Earnings Reports

OnKure Therapeutics | 10-Q: Quarterly report

Nov 7 16:03 ET

Reneo Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 13 17:08 ET

Reneo Pharmaceuticals | 8-K: Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results

Aug 13 16:02 ET

Reneo Pharmaceuticals | 8-K: Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

May 7 22:16 ET

Analyst Rating

Updated: Oct 17, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall